Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 45 of 45 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company AccuNovo Biotechnologies Inc. | Activity: Research and Development | Company Description Accunovo is developing novel targeted PET imaging probes through a combination of unique biomarker-binding molecules and imaging-guided precision radiopharmaceuticals for solid tumors. | Location Chapel Hill | |
Company Ad Astra Diagnostics Inc. | Activity: Research and Development | Company Description Ad Astra Diagnostics develops rapid human health diagnostics and data systems. | Location Morrisville | |
Company Aestas Pharma Inc. | Activity: Research and Development | Company Description Aestas Pharma develops novel diagnostic imaging and disease-modifying therapeutic agents to enable the detection, early treatment and reversal of Alzheimer’s disease when clinical signs are not yet pronounced. | Location Durham | |
Company Affinergy LLC | Activity: Research and Development | Company Description Affinergy develops diagnostic tools for rare and difficult to diagnose diseases. Affinergy's development programs include rapid assays for proteins, drugs, cells and small molecules. | Location Durham | |
Company Appealing Products Inc. | Activity: Research and Development | Company Description Appealing Products develops products for forensics and personal protection from toxic materials such as inorganics, gases and poisons in foods, animal feeds and liquids. | Location Raleigh | |
Company Arcus-Med LLC | Activity: Research and Development | Company Description Arcus-Med is developing software to diagnose pulmonary hypertension (PH). | Location Raleigh | |
Company Atom Bioworks Inc. | Activity: Research and Development | Company Description Atom Bioworks has developed a platform for programming DNA/RNA-based biomolecules as high-affinity binding reagents. | Location Cary | |
Company Biofidelity Inc. | Activity: Research and Development | Company Description Biofidelity provides simple, high-sensitivity diagnostic assays which enable patient monitoring and precision medicine. | Location Morrisville | |
Company Bloodless Dx LLC | Activity: Research and Development | Company Description Bloodless Dx is an assay development company focused on bloodless diagnostics. | Location Apex | |
Company Cellex Inc. | Activity: Research and Development | Company Description Cellex develops, manufactures and markets diagnostic tests suitable for point-of-care use. These tests use a platform technology called Homogeneous Biochemiluminescence Assay (HBA), which enables assays that are highly sensitive and easy-to-use. | Location Cary | |
Company Datar Cancer Genetics | Activity: Research and Development | Company Description Datar Cancer Genetics develops blood-based diagnostics for early cancer detection and identifies personalized treatment strategies based on genomic and cellular analysis of a patient's cancer. | Location Morrisville | |
Company Diabetic Health Inc. | Activity: Research and Development | Company Description Diabetic Health develops coatings to improve the longevity and performance of continuous glucose monitoring sensors (CGM) and insulin infusion sets used in diabetes management. | Location Research Triangle Park | |
Company Domus Diagnostics | Activity: Research and Development | Company Description Domus Diagnostics is a point-of-care diagnostics company that develops accurate, rapid molecular tests for infectious diseases. | Location Durham | |
Company Endacea Diagnostics Inc. | Activity: Research and Development | Company Description Endacea Diagnostics is developing EndaTox IVD, an in vitro sepsis diagnostic, and EndaTox Test, an assay to measure LPS endotoxin in biological and non-biological samples. | Location Research Triangle Park | |
Company Endacea Inc. | Activity: Research and Development | Company Description Endacea develops A1 adenosine receptor antagonists as drug candidates for cancer, COVID-19 acute lung injury, sepsis and acute renal failure. | Location Research Triangle Park | |
Company Entegrion Inc. | Activity: Research and Development | Company Description Entegrion offers a novel point of care in vitro diagnostic blood coagulation monitoring system for use in human and veterinary medicine. | Location Durham | |
Company EydisBio Inc. | Activity: Research and Development | Company Description Eydis Bio is developing a platform of small molecule therapeutics targeting a variety of diseases driven by aberrant inflammatory/autoimmune processes. | Location Durham | |
Company Galaxy Diagnostics Inc. | Activity: Contract Research and Testing | Company Description Galaxy Diagnostics offers advanced molecular and serology testing for hard-to-detect flea- and tick-borne infections. It serves physicians, veterinarians and clinical researchers. | Location Durham | |
Company Gemelli Biotech | Activity: Sales and Operations | Company Description Gemelli Biotech develops diagnostics and therapeutics for microbiome diseases. | Location Raleigh | |
Company GeneCentric Therapeutics Inc. | Activity: Research and Development | Company Description GeneCentric Therapeutics develops molecular diagnostic assays to enable oncologists and their patients to make informed, individualized treatment decisions. | Location Research Triangle Park | |
Company Hemo Bioscience Inc. | Activity: Production and Manufacturing | Company Description Hemo Bioscience is an FDA-registered, ISO 13485-accredited manufacturer of blood-typing reagents and diagnostics for the blood-banking industry. | Location Durham | |
Company HIPRA Scientific USA LLC | Activity: Research and Development | Company Description Hipra researches and develops vaccines, diagnostics and pharmaceuticals for animal health. | Location Raleigh | |
Company Inanovate Inc. | Activity: Research and Development | Company Description Inanovate has developed a patented blood analysis system (the Bio-ID) for diagnostic tests. The first application of the Bio-ID is a new blood test to detect breast cancer recurrence at a stage when it may still be cured. | Location Chapel Hill | |
Company Jericho Sciences LLC | Activity: Research and Development | Company Description Jericho Sciences is developing antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 infection to reduce underlying sources of persistent virus. | Location Durham | |
Company Juno Metabolomics LLC | Activity: Production and Manufacturing | Company Description Juno Metabolomics is developing next-generation metabolomics for precision medicine. | Location Chapel Hill | |
Company Kalia Health | Activity: Research and Development | Company Description Kalia Health develops home-based early detection tests for pregnancy complications like preeclampsia and eclampsia for use in low-resource settings. | Location Chapel Hill | |
Company Lucerno Dynamics LLC | Activity: Research and Development | Company Description Lucerno Dynamics is commercializing a medical device for quality control, dosimetry, and quality assurance for nuclear medicine. Future applications of the technology include rheumatoid arthritis, immunotherapy, and chemotherapy assessment. | Location Cary | |
Company MDxHealth Inc. | Activity: Research and Development | Company Description MDxHealth develops epigenetic technologies to personalize the diagnosis and treatment of cancer. | Location Hillsborough | |
Company MIDAS Biotech LLC | Activity: Research and Development | Company Description MIDAS Biotech develops in vitro diagnostic products. | Location Morrisville | |
Company New Hope Biodiagnostics LLC | Activity: Research and Development | Company Description New Hope Biodiagnostics is developing biodiagnostics for cancer. | Location Chapel Hill | |
Company NIRvana Sciences Inc. | Activity: Research and Development | Company Description NIRvana Sciences is commercializing red and near-infrared fluorescent dyes for use in diagnostics and imaging applications. | Location Research Triangle Park | |
Company OrangeBiomed Inc. | Activity: Sales and Operations | Company Description Orange Biomed is a healthcare startup developing diabetes management technology. | Location Hillsborough | |
Company Path BioAnalytics Inc. | Activity: Research and Development | Company Description Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation of treatments for individuals living with respiratory disease. | Location Durham | |
Company PETNET Solutions Inc., A Siemens Healthineers Company (Durham) | Activity: Production and Manufacturing | Company Description PETNET manufactures positron emission tomography (PET) radiopharmaceuticals. | Location Durham | |
Company Precision Diabetes Inc. | Activity: Sales and Operations | Company Description Precision Diabetes is developing a spectrum of unique diabetes tests, from detecting the risk of developing diabetes to diagnosing complications from diabetes. | Location Cary | |
Company Quanticision Diagnostics Inc. | Activity: Contract Research and Testing | Company Description Quanticision Diagnostics measures tissues biomarkers for solid tumor diagnosis and supplies multi-unit plates for high throughput immunoblot analysis. | Location Research Triangle Park | |
Company Resonantia Diagnostics | Activity: Research and Development | Company Description Resonantia Diagnostics is a startup developing a point of care diagnostic platform that rapidly identifies a pathogen from a clinical specimen and determines the pathogen's antimicrobial susceptibility. | Location Durham | |
Company Revvity | Activity: Research and Development | Company Description Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development. | Location Durham | |
Company Sapere Bio Inc. | Activity: Research and Development | Company Description Sapere Bio develops biomarkers of aging for clinical use to help physicians predict risk of chemotherapy-induced toxicities and surgery-associated adverse events in various patient groups. | Location Research Triangle Park | |
Company Trana Discovery Inc. | Activity: Research and Development | Company Description Trana Discovery provides an anti-infective discovery platform that enables its partners to identify novel treatments with pathogen-focused spectrums of activity for bacterial, viral and fungal infectious diseases by inhibiting tRNA not possessed by humans or crops. | Location Cary | |
Company Vascular BioSciences Inc. | Activity: Research and Development | Company Description Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases. | Location Durham | |
Company Vero Diagnostics LLC | Activity: Contract Research and Testing | Company Description Vero Diagnostics offers comprehensive diagnostic testing, including urine and oral fluid drug monitoring, pathogen detection, Pharmacogenomics (PGx) testing and blood testing. | Location Apex | |
Company Vizma.AI | Activity: Research and Development | Company Description Vizma.AI provides diagnostic molecular insights to oncologists, cardiologists and neurologists with non-invasive and patient-centric technology. | Location Chapel Hill | |
Company Xenobiotic Detection Systems International Inc. | Activity: Contract Research and Testing | Company Description Xenobiotic Detection Systems offers patented bioassays to facilitate assessment of environmental and human health risks. | Location Durham | |
Company Zymeron Corporation | Activity: Research and Development | Company Description Zymeron develops and commercialize technologies to detect, prevent and treat infectious diseases, immune disorders and emerging pathological threats. | Location Durham |